Shopping Cart
- Remove All
Your shopping cart is currently empty
SST0116CL1 is an HSP90 inhibitor (IC50: 0.21 μM) that targets the ATP-binding pocket of Hsp90, disrupting its chaperone function and leading to the degradation of client proteins (EGFR, CDK4, and AKT). It induces the degradation of Her2 in BT-474 cells (IC50: 0.2 μM) and exhibits antiproliferative activity, inhibiting tumor growth.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,350 | 3-6 months | |
| 50 mg | $3,140 | 3-6 months | |
| 100 mg | $4,160 | 3-6 months |
| Description | SST0116CL1 is an HSP90 inhibitor (IC50: 0.21 μM) that targets the ATP-binding pocket of Hsp90, disrupting its chaperone function and leading to the degradation of client proteins (EGFR, CDK4, and AKT). It induces the degradation of Her2 in BT-474 cells (IC50: 0.2 μM) and exhibits antiproliferative activity, inhibiting tumor growth. |
| In vitro | SST0116CL1 inhibits the proliferation of various tumor cells, with IC 50 values as follows: 0.81 μM (A431), 0.11 μM (NCI-H460), 0.81 μM (A2780), 0.40 μM (MV4;11), 0.23 μM (GTL-16), 0.62 μM (BT474), and 0.34 μM (HT-1080). |
| Molecular Weight | 482.96 |
| Formula | C22H31ClN4O6 |
| Cas No. | 1799802-29-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.